Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: Application to bioequivalence studies

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 4, 2010, Pages 985-990

  Tutunji, Lara F ^a,b   Tutunji, Maha F ^a,b   Alzoubi, Mamoun I ^b   Khabbas, Manal H ^b   Arida, Adi I ^c  

^a UNIVERSITY OF JORDAN   (Jordan)

^b PharmaquestJo   (Jordan)

^c PHILADELPHIA UNIVERSITY   (Jordan)

Author keywords

Bioequivalence; Hydrochlorothiazide; Irbesartan; LC MS MS; Simultaneous

Indexed keywords

DICLOFENAC; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS IRBESARTAN; IRBESARTAN; LOSARTAN; PARACETAMOL; THEOPHYLLINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG MONITORING; ELECTROSPRAY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRECIPITATION; PRIORITY JOURNAL; SINGLE DRUG DOSE; TABLET FORMULATION; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BIPHENYL COMPOUNDS; CALIBRATION; CHEMICAL PRECIPITATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DIURETICS; DRUG COMBINATIONS; DRUG STABILITY; HUMANS; HYDROCHLOROTHIAZIDE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TABLETS; TANDEM MASS SPECTROMETRY; TETRAZOLES; THERAPEUTIC EQUIVALENCY; YOUNG ADULT;

EID: 72149098112     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.10.023     Document Type: Article

References (27)

1. Lant A. Drugs 29 (1985) 162-188
2. Manalan A.S., Besch Jr. H.R., and Watanabe A.M. Circulation Research 49 (1981) 326-336
3. Croom K.F., Curran M.P., Goa K.L., and Perry C.M. Drugs 64 (2004) 999-1028
4. Neutel J.M., Saunders E., Bakris G.L., Cushman W.C., Ferdinand K.C., Ofili E.O., Sowers J.R., and Weber M.A. Journal of Clinical Hypertension 7 (2005) 578-586
5. Neutel J.M., Franklin S.S., Lapuerta P., Bhaumik A., and Ptaszynska A. Journal of Human Hypertension 22 4 (2008) 266-274
6. Weir M.R., Neutel J.M., Bhaumik A., De Obaldia, Maria Elena, and Lapuerta P. Journal of Clinical Hypertension 9 Suppl. 5 (2007) 23-30
7. Hsieh J.Y.K., Lin C., Matuszewski B.K., and Dobrinska M.R. Journal of Pharmaceutical and Biomedical Analysis 12 (1994) 1555-1562
8. De Vries J.X., and Voss A. Biomedical Chromatography: BMC 7 (1993) 12-14
9. Van der Meer M.J., and Brown L.W. Journal of Chromatography-Biomedical Applications 423 (1987) 351-357
10. Medvedovici A., Mircioiu C., David V., and Miron D.S. European Journal of Drug Metabolism and Pharmacokinetics 25 (2000) 91-96
11. Erk N. Journal of Liquid Chromatography & Related Technologies 26 (2003) 2581-2591
12. Chmielewska A., Konieczna L., Plenis A., and Lamparczyk H. Journal of Chromatography B 839 (2006) 102-111
13. Li L., Sun J., Yang P., and He Z. Analytical Letters 39 (2006) 2797-2807
14. Vonaparti A., Kazanis M., and Panderi I. Journal of Mass Spectrometry 41 (2006) 593-605
15. Tutunji M.F., Ibrahim H.M., Khabbas M.H., and Tutunji L.F. Journal of Chromatography B 877 (2009) 1689-1697
16. Song M., Hang T., Zhao H., Wang L., Ge P., and Ma P. Rapid Communication Mass Spectrometry 21 (2007) 3427-3434
17. Li H., Wang Y., Jiang Y., Tang Y., Wang J., Zhao L., and GU J. Journal of Chromatography B 852 (2007) 436-442
18. Ramakrishna N.V.S., Vishwottam K.N., Manoj S., Koteshwara M., Wishu S., and Varma D.P. Biomedical Chromatography 19 (2005) 751-760
19. Fang W., Xie W., Hsieh J.Y.K., and Matuszewski B.K. Journal of Liquid Chromatography & Related Technologies 28 (2005) 2681-2703
20. Sane R.T., Francis M., and Pawar S. Indian Drugs 40 (2003) 104-110
21. Shakya A.K., Al-Hiari Y.M., and Alhamami O.M.O. Journal of Chromatography B 848 (2007) 245-250
22. Wang W.L., and Liu Q. Zhongguo Yaofang 18 (2007) 2512-2513
23. Chen X., Guan X., Song B., Zhang Y., and Zhong D. Zhongguo Yaoxue Zazhi (Beijing, China) 42 (2007) 1486-1489
24. Erk N. Journal of Chromatography B 784 (2003) 195-201
25. Najma S., Saeed A.M., Shahid A.S., and Shahnawaz S. Chinese Journal of Chromatography 26 (2008) 544-549
26. Emea. Note for Guidance on the Investigation of Bioavailability and Bioequivalence (July, 2001). http://apps.who.int/prequal/info_applicants/BE/emea_bioequiv.pdf http://apps.who.int/prequal/info_applicants/BE/emea_bioequiv.pdf
27. FDA. Guidance of Industry, Bioanalytical Method Validation (May, 2001). http://www.fda.gov/cder/guidance/4252fnl.pdf http://www.fda.gov/cder/guidance/4252fnl.pdf